skin lesions | sciencenewsnet.in

Breaking News

Researchers Uncover Achilles Heel of Antibiotic-Resistant Bacteria

New research sheds light on a surprising connection between COVID-19 and cancer regression

Research finds no significant negative impact of repealing a Depression-era law allowing companies to pay workers with disabilities below minimum wage

Low-frequency magnetic field (LFMF) for enhanced carotenoids production by Rhodotorula glutinis

AAOS Sweeps Three Top Workplace Honors Locally and Nationally in 2024

Texas Tech Health El Paso Schools Recognized in U.S. News & World Report’s Best Colleges Rankings

University of Chicago Medical Center Receives 26th Consecutive “A” in Hospital Safety from Leapfrog Group

Hackensack Meridian Jersey Shore University and Hackensack University Medical Centers Achieve Excellence in Life Support Care

International Cancer Organizations Present Collaborative Work During Oncology Event in China

ETRI-F&U Credit Information Co., Ltd., Opens a New Path for AI-Based Professional Consultation

15 Nov, 2024

UC Davis Health study reports on the safety, efficacy of tecovirimat in treating monkeypox

August 26, 2022 sarah JonasResearch Results

UC Davis Health has published one of the earliest studies assessing the use of tecovirimat to treat monkeypox (MPX) symptoms and skin lesions. The antiviral drug approved for smallpox treatment appeared to be safe and effective in 25 patients with monkeypox.